Bronchopulmonary dysplasia

Respiratory Care

Volumn 54, Issue 9, 2009, Pages 1252-1262

  Deakins, Kathleen M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

BPD; Bronchopulmonary dysplasia; Surfactant replacement

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; CAFFEINE; CHLOROTHIAZIDE; CORTICOSTEROID; DEXAMETHASONE; DIURETIC AGENT; FUROSEMIDE; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; INOSITOL; NITRIC OXIDE; RETINOL; SPIRONOLACTONE; SUPEROXIDE DISMUTASE; SURFACTANT;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC THERAPY; APNEA; ARTIFICIAL VENTILATION; CEREBRAL PALSY; CONFERENCE PAPER; CORTICOSTEROID THERAPY; DELIVERY ROOM; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE COURSE; DIURETIC THERAPY; HUMAN; INFECTION PREVENTION; INTESTINE PERFORATION; INVASIVE PROCEDURE; LONG TERM CARE; LOW DRUG DOSE; LUNG DISEASE; LUNG DYSPLASIA; NEUROLOGIC DISEASE; NON INVASIVE PROCEDURE; NUTRITION; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PREMATURITY; RESPIRATORY CARE; RESPIRATORY CARE PRACTICE; SUBSTITUTION THERAPY; SYSTEMIC THERAPY; UNSPECIFIED SIDE EFFECT;

BRONCHODILATOR AGENTS; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; OXYGEN INHALATION THERAPY; POSITIVE-PRESSURE RESPIRATION; PULMONARY SURFACTANTS; STEROIDS;

EID: 70349113959     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Greenhough A, Premkumar M, Patel D. Ventilatory strategies for the extremely premature infant. Paediatr Anaesthesia 2008;18(5)371-377.
2. Baraldi E, Fillipone M. Chronic lung disease after premature birth. N Engl J Med 2007;357(19):1946-1955. (Pubitemid 350074689)
3. Ramanathan R. Optimal ventilatory strategies and surfactant to protect the preterm lungs. Neonatology 2008;93(4):302-308. (Pubitemid 351799114)
4. Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004;114(5)1305-1311. (Pubitemid 41647693)
5. Tin W, Wiswell TE. Adjunctive therapies in chronic lung disease: examining the evidence. Semin Fetal Neonatal Med 2008;13(1)44-52. (Pubitemid 350298988)
6. Ambalavanan N, Carlo W. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):192-199. (Pubitemid 44062677)
7. Kinsella J, Greenough A, Abman SA. Bronchopulmonary dysplasia. Lancet 2006;367(9520):1421-1431.
8. Bhandari A, Panitch HB. Pulmonary outcomes in bronchopulmonary dysplasia. Semin Perinatol 2006;30(4)219-226.
9. Cerny L, Torda JS, Rehan VK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 2008;186(2):75-89.
10. Hutchison AA, Bignall S. Non-invasive positive pressure ventilation in the preterm neonate: reducing endotrauma and the incidence of bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 2008;93(1):F64-F68.
11. Ryan RM. A new look at bronchopulmonary dysplasia classification. J Perinatol 2006;26(4):207-209.
12. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163(7):1723-1729.
13. Erickson SJ, Grauaug A, Gurrin L, Swaminathan M. Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia. J Paediatr Child Health 2002;38(6):560-562. (Pubitemid 35370561)
14. Driscoll W, Davis J. Bronchopulmonary dysplasia: differential diagnosis & workup. E Medicine from Web MD 2007 [Internet]. Updated April 23, 2007. Available from http://emedicine.medscape.com/article/973717-diagnosis. Accessed August 6, 2009.
15. Attar MA, Donn SM. Mechanisms of ventilator induced lung injury in premature infants. Semin Neonatol 2002;7(5):353-360. (Pubitemid 35440220)
16. Keszler M. State of the art in conventional mechanical ventilation. J Perinatol 2009;29(4):262-275.
17. Gagliardi L, Bellù R, Rusconi F, Merazzi D, Mosca F Antenatal steroids and risk of bronchopulmonary dysplasia: a lack of effect or a case of over-adjustment? Paediatr Perinat Epidemiol 2007;21(4):347-353.
18. Lacaze-MasMonteil L, Hartling Y, Liang C, Freisen C. A systematic review and meta-analysis of studies evaluating chorioamnionitis as a risk factor for bronchopulmonary dysplasia in preterm infants. Paediatr Child Health 2007;12(Suppl A).
19. Choi CW, Beyong K, Joung KE, Lee JE, Lee YK, Kim HS, et al. Decreased expression of transforming growth factor-beta1 in bronchoalveolar lavage cells of preterm infants with maternal chorioamnionitis. J Korean Med Sci 2008;23(4):609-615.
20. Ramanathan V. Infection and preterm birth: evidence of a common causal relationship with bronchopulmonary dysplasia and cerebral palsy. J Paediatr Child Health 2001;36(4):293-296.
21. Morley CJ, Davis PG. Continuous positive airway pressure: scientific and clinical rationale. Curr Opin Pediatr 2008;20(2):119-124.
22. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005;112(24 Suppl):IV1-IV203.
23. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care of pediatric and neonatal patients: neonatal resuscitation guidelines. Pediatrics 2006;117(5)e1029-e1038.
24. Kabra NS, Schmidt S, Roberts R, Doyle L, Fanaroff A, Papile, L. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007;150(3):229-234. (Pubitemid 46343549)
25. Harling AE, Beresford MW, Vince GS, Bates MY, Yoxall CW. Does sustained lung inflation at resuscitation reduce lung injury in the preterm infant. Arch Dis Child Fetal Neonatal Ed 2005;90(5):F406-F410. (Pubitemid 41224076)
26. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510.
27. Bancalari E, del Moral T. Bronchopulmonary dysplasia and surfactant. Biol Neonate 2001;80(Suppl 1):7-13.
28. Higgins RD, Bancalari E, Willinger M, Raju T. Executive summary of the workshop on oxygen in neonatal therapies: controversies and opportunities for research. Pediatrics 2007;119(4):790-796. (Pubitemid 46556680)
29. Sola A, Saldeno. Falvareto V. Clinical practices in neonatal oxygenation: where have we failed and what can we do? J Perinatol 2008;28(Suppl 1):S28-S34.
30. Thomas W, Speer C. Management of infants with bronchopulmonary dysplasia in Germany. Early Human Dev 2005;81(2):155-163. (Pubitemid 40320905)
31. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed limitation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002;(2):CD002795.
32. Aly H, Massaro AN, Patel K, El-Mohandes AA. Is it safer to intubate premature infants in the delivery room? Pediatrics 2005;115(6):1194-1201.
33. Claure N, Bancalari E. New modes of mechanical ventilation in the preterm newborn: evidence of benefit. Arch Dis Child Fetal Neonatal Ed 2007;92(6):F508-F512. (Pubitemid 350044012)
34. Greenough A, Premkumar M, Patel D. What is new in ventilation strategies for the neonate? Eur J Pediatr 2007;166:991-996.
35. Singh J, Sinha SK, Donn SM. Volume targeted ventilation of newborns. Clin Perinatol 2007;34(1):93-105.
36. Guthrie SO, Lynn C, LaFLeur BJ, Donn SM, Walsh WF. A crossover analysis of mandatory minute ventilation compared to synchronized intermittent mandatory ventilation. J Perinatol 2005;25(10):643-646. (Pubitemid 41486250)
37. Carlo WA, Miller JD. Permissive hypercapnia in neonates. Neo Rev 2007;8(8):e345.
38. Kraybill EN; Runyan DK; Bose CL; Khan JH. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 1989;115(1):115-120
39. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen saturation targets and outcomes in extremely premature infants. N Engl J Med 2003;349(10):959-967. (Pubitemid 37064769)
40. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354(20):2112- 2121.
41. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006;355(4):343-353. Erratum in: N Engl J Med 2007;357(14):1444-1445.
42. Barrington KJ, Finer N. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2007;(3):CD000509. (Pubitemid 351805525)
43. Pantalitschka T, Poets CF. Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia. Pediatr Pulmonol 2006;41(8):703-708. (Pubitemid 44157352)
44. Hintz S. Bronchodilator aerosol therapy in the preterm infant. Neo Rev 2003;4:9e245.
45. Suchomski SJ, Cummings JJ. A randomized trial of inhaled versus intravenous steroids in ventilator-dependent preterm infants. J Perinatol 2002;22(3):196-203. (Pubitemid 34461096)
46. Walther FJ, Findlay RD, Durand M. Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Dev 2003;74(1):37-45. (Pubitemid 37152488)
47. Brion LP, Primhak R, Yong R. Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2006;(3):CD001694.
48. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC, et al. Prophylaxis in early adrenal insufficiency to prevent BPD: a multi center trial. Pediatrics 2004;114(6):1649-1657.
49. Woolridge N. Pulmonary diseases. In: H. K. Samour PQ. Handbook of pediatric nutrition. New York: Jones & Bartlett Publishers; 2005:307-349.
50. Lonnerdal B. Iron metabolism in infants. CRC Press; 1989.
51. Korones SB. Complications. In: Goldsmith JP, Karotkin EH, editors: Assisted ventilation of the neonate. 4th edition. Philadelphia: WB Saunders; 2004:347-348.
52. Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2003;(4):CD000366.